Search

everythinglearnresearchcommunity

for

Search:↓

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

Diphencyprone initially increases mouse hair growth, then slows it, possibly due to changes in specific protein levels.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Blocking a key energy pathway in human hair follicles can trigger stress responses that stop cell growth.

SPET-085 effectively inhibits an enzyme linked to prostate issues, similar to finasteride.

Finasteride modifies 5-alpha-reductases through a two-step process, affecting inhibitor potency and possibly causing side effects.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Finasteride blocks progesterone's effect on brain activity linked to epilepsy.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Finasteride may affect PNMT, causing side effects.

A new method was developed to make finasteride for treating hair loss.

Removing the ROBO4 gene in mice reduces skin inflammation and hair loss by affecting certain inflammation pathways and gene expression.

PDE3 inhibitor may help treat hair loss by promoting hair growth.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Finasteride increases P-glycoprotein activity in the liver and kidney.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Finasteride effectively blocks rat enzymes, but with varying methods and strength.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Epristeride's metabolism in zebrafish helps improve doping detection methods.

Compound 15a was effective in inhibiting 5α-reductase.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Pioglitazone may help treat lichen planopilaris, but more research is needed.